Sanofi-Aventis finished its due diligence of Genzyme's books and facilities but the two drug makers have yet to settle on a price.
WSJ.com: What's News US, Wall Street Journal: Home US
Sun, 02/13/2011 - 5:18pm
Sanofi-Aventis finished its due diligence of Genzyme's books and facilities but the two drug makers have yet to settle on a price.